Please assess the completion status of the following clinical trial:

Trial Title: A Trial of Digoxin Before Second-Trimester Abortion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* at least 18 years old~* English or Spanish speaking~* be able to give informed consent~* documented fetal cardiac activity.~Exclusion Criteria:~* significant medical illness or cardiovascular disease~* current use of cardiac or antihypertensive medications~* cardiac arrhythmia on preoperative EKG~* multiple gestation~* morbid obesity (BMI greater than 40)~* known digoxin allergy

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- intra-fetal injection (Type: ACTIVE_COMPARATOR): Subjects will receive an intra-fetal digoxin injection one day prior to their second-trimester surgical abortion
- intra-amniotic injection (Type: ACTIVE_COMPARATOR): Subjects will receive an intra-amniotic digoxin injection one day prior to their second-trimester surgical abortion

Based on this trial design, predict the completion outcome and termination type (if applicable).